Careaga-Reyna G, Zetina-Tun HJ, Galván-Díaz J, Álvarez-Sánchez LM

Language: Spanish
References: 6
Page: 196-198
PDF size: 198.53 Kb.

ABSTRACT

The treatment of refractory terminal heart failure has been heart transplantation. However, there are limitations with regard to clinical conditions of the recipient and availability of donors, and ventricular support has therefore been alternatively used as destination therapy. We describe the case is of a female patient with ischemic cardiomyopathy-associated heart failure who had a left ventricular assist device successfully implanted and at eight months of the procedure was at functional class I, with no complications.

REFERENCES

1. Careaga-Reyna G, Zetina-Tun H, Lezama-Urtecho CA. Programa de trasplante cardiaco de la Unidad Médica de Alta Especialidad, Hospital General Dr. Gaudencio González Garza del Centro Médico Nacional “La Raza”. Rev Invest Clin. 2011;63 85-90.

2. Stehlik J, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dobbels F, et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-eighth adult heart transplant report-2011. J Heart Lung Transplant. 2011;30:1078-1094.

3. Mancini D, Colombo PC. Left ventricular assist devices: a rapidly evolving alternative to transplant. J Am Coll Cardiol. 2015;65 2542-2555.

4. Kirklin JK, Naftel DC, Kormos RL, Pagani FD, Myers SL, Stevenson LW, et al. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device. J Heart Lung Transplant. 2014;33:12-22.

5. Estep JD, Starling RC, Horstmanshof DA, Milano CA, Selzman CH, Shah KB, et al. Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: results from the ROADMAP. J Am Coll Cardiol. 2015;66:1747-1761.

6. Echeverría L, Salazar L, Torres A, Figueredo A. Dispositivos de asistencia ventricular: una realidad en Colombia. Rev Colomb Cardiol. 2016;23:49-54.